News and Events

Keep up-to-date on recent events, webinars and releases from ArcherDX.



Dec
5
2017

Archer at ASH 2017

ArcherDX at the American Society of Hematology in Atlanta, GA from December 9-12, 2017


Nov
14
2017

Press release: ArcherDX receives EN ISO 13485 certification for medical device quality management

ArcherDX announces ISO 13485:2003 & EN ISO 13485:2012 certification indicating that the company’s quality management system maintains standards specific to medical devices, including in vitro diagnostic (IVD) assays


Nov
10
2017

Press release: ArcherDX, Celgene ink CDx development agreement

ArcherDX, Celgene ink worldwide companion diagnostic agreement relating to investigational drug CC-122


Oct
6
2017

ArcherDX at AMP 2017

Boost your molecular pathology research with Archer NGS assays, presenting at AMP 2017, Salt Lake City, UT Nov 16-18, Booth #1619


Oct
5
2017

Webinar - Archer VariantPlex myeloid assays

In this webinar we discuss how updates to the assay and software provide better coverage over challenging regions and enable lower limits of detection, high-resolution CNV detection and lightning-fast analysis that leverage and maximize the unique power of the patented Anchored Multiplex PCR (AMP™) target enrichment chemistry used in Archer NGS assays.


Aug
2
2017

ArcherDX expands blood-based mutation assay portfolio with new myeloid panels

ArcherDX launches two new NGS-based NGS-based variant-detection assays, the 37-gene VariantPlex Core Myeloid and 72-gene VariantPlex Myeloid panel with unprecedented levels of confident mutation detection.


Jun
12
2017

ArcherDX presents at EHA 2017 in Madrid, Spain

ArcherDX presents at the 22nd European Hematology Association Congress in Madrid, Spain


Apr
24
2017

Archer sponsors Breast Cancer research platform

ArcherDX is partnering with Susan G. Komen Colorado and the University of Colorado Cancer Center to create a local event to connect community physicians, patients, and advocates with academic researchers and industry leaders. Our vision is to provide an educational forum to raise awareness about advances in breast cancer research, treatment, and testing.


Apr
20
2017

Archer at Immunology 2017

Archer exhibits at the American Association of Immunologists Annual Meeting–Immunology 2017 in Washington, DC. At the largest annual gathering of immunologists worldwide, scientists discuss breakthroughs across the full spectrum of topics in the Immunology.


Apr
19
2017

Archer attends the Children's Oncology Group Cytogenetics Workshop 2017

Archer attends the Children's Oncology Group Cytogenetics Workshop 2017


Apr
19
2017

Archer presents workshop at Biomarkers and Immuno-Oncology World Congress 2017

We'll be exhibiting at Cambridge Healthtech Institute’s Thirteenth Annual Biomarkers and Immuno-Oncology World Congress and will presenting a poster and a workshop featuring on B- and T-Cell Immune Repertoire Characterization by Anchored Multiplex PCR and Next-Generation Sequencing. This conference is dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines.


Apr
18
2017

Archer at 106th Annual Meeting of Japanese Society of Pathology in Tokyo

We'll be co-attending with Illumina at the inaugural Japanese Society of Pathology in Tokyo. We'll be presenting five posters at this event and giving away corresponding poster flyers with the lead scientist contact info for later review. This gathering will strive to establish a focus on diagnosis that is based on an integrated understanding of disease through the use of high-sensitivity, high-volume analytical technologies like next-generation sequencers and embrace the ideal of giving something back to medicine and society as the goal of pathology.


Apr
3
2017

Meet us at the Rocky Mountain Blood Cancer Conference

Archer is Denver on April 8th promoting awareness of NGS in blood cancer cancer research at the Rocky Mountain Blood Cancer Conference hosted by the Leukemia and Lymphoma Society. This a free educational conference for patients, survivors, caregivers and healthcare professionals.


Apr
3
2017

ArcherDX announces strategic partnership with Chinese firm HeliTec for NGS-based diagnostic development

ArcherDX, the leader in NGS-based oncology sequencing applications, and the precision medicine company HeliTec announced today a strategic partnership to advance NGS-based cancer diagnostic development in China. The partnership will entail co-developing and cross-licensing NGS-based technologies with the goal of registering oncology diagnostic kits with the Chinese Food and Drug Administration (CFDA).


Mar
15
2017

AMP Global 2017

Meet us in Berlin, Germany this April for the inaugural AMP 2017 Global Congress on Molecular Pathology: Diagnostic Technologies and Clinical Applications. A multi-disciplinary scientific program showcases molecular technology with clinical applications in oncology (solid tumors, hematopathology), genetics (congenital, heritable), and infectious diseases.


Mar
3
2017

Archer sponsors Snowshoe for the Cure

Archer partners with Susan G. Komen Colorado for the Snowshoe for the Cure. A truly unique event that combines the community's philanthropic spirit with Coloradans' love for the great outdoors - all in an effort to combat the most frequently diagnosed cancer worldwide. Upwards of 1,500 enthusiastic participants strap on their snowshoes in an effort to stomp out breast cancer, a disease that impacts 1 in every 7 women in Colorado.


Mar
1
2017

Archer at the 2017 ACMG Annual Clinical Genetics Meeting

Meet us in Phoenix, AZ this March for the 2017 ACMG Annual Clinical Genetics Meeting. The ACMG provides genetics professionals with the opportunity to learn how genetics and genomics are being integrated into medical or clinical practice. ArcherDX addresses the bottlenecks associated with using NGS in translational research by offering a robust platform for targeted sequencing applications.


Mar
1
2017

AACR Annual Meeting 2017

The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research.


Jan
17
2017

Archer exhibits at USCAP 2017 Annual Meeting

Meet us in San Antonio, TX this March for The USCAP 2017 Annual Meeting. This conference boasts the largest gathering of Pathologists in the world. We will be presenting posters illustrating our latest technologies including detection of mutations in ctDNA and B- and T-cell immune repertoire characterization with Anchored Multiplex PCR and Next-Generation Sequencing.


Jan
17
2017

Festival of Genomics London 2017

Join us at the 2017 Festival of Genomics in London this January. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer® is unleashing the power of translational NGS to enable mutation detection.


Jan
17
2017

Archer presents at Molecular Med TRI-CON 2017

Join us at Molecular Med TRI-CON 2017 in San Francisco this February. This conference focuses on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology. Our featured talk will be Improving NGS-Based Liquid Biopsy Mutation Detection with Anchored Multiplex PCR presented by Archer CSO, General Manager, Josh Stahl.


Jan
17
2017

Precision Medicine World Conference 2017

Join us for the Precision Medicine World Conference in Silicon Valley, January 24-27th. By combining revolutionary AMP™ chemistry with an easy workflow and intuitive software, Archer is unleashing the power of translational NGS to enable mutation detection.


Dec
20
2016

Detecting meaningful mutations from liquid biopsies by Anchored Multiplex PCR

In this webinar, Josh Stahl and Jonathan Doose from ArcherDX will describe AMP-based ctDNA library preparation method, highlighting the use and advantages of molecular barcoded adapters used to unambiguously remove PCR duplicates, correct for PCR or sequencer-derived sequence errors, and flag run-to-run contamination. They will then talk about how the Archer® Reveal ctDNA™ 28 kit uses AMP combines robust variant detection and quantitative analysis with single-day library prep for powerful, accurate and fast mutation analysis from liquid biopsies.


Dec
16
2016

From enhanced variant calling to immune repertoire analysis: Greater assay design and analytics with Archer software updates

In this webinar, Brent Lutz, Product Manager of Software, and Doug Wendel, Senior Director of Software, will detail new Assay Designer and Analysis features designed to leverage and maximize the unique power of the patented Anchored Multiplex PCR (AMP™) target enrichment chemistry used in Archer NGS assays. Their talk will cover: • Enhanced variant calling via error correction and multi-sample noise reduction • Immune repertoire analysis • Archer Quiver™ Fusion Database customization • REST API for robust workflow integration • Mix & match cached targets for simple and fast custom assays • Integration with third party reporting providers

Subscribe to stay in the loop







How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.